About this podcast
Weekly digest of new research on acromegaly — trials, therapies, and clinical updates.
Episodes
The newest 20 of 30 episodes
- Acromegaly Update — Monday November 16, 2026 · 7 minAnother incremental week for acromegaly research, led by evidence that upper-limb joint damage is nearly universal in patients and an early AI voice test for diagnosis, while…
- Acromegaly Update — Monday November 9, 2026 · 5 minA quiet week for top-tier acromegaly papers, with a useful surgical-outcome predictor and a new treatment-landscape review, while rare disease industry news was dominated by…
- Acromegaly Update — Monday November 2, 2026 · 4 minA quiet week for acromegaly, with no top-tier-journal papers and only incremental observational work (tumor size drives headache; surgical remission isn't predicted by tumor…
- Acromegaly Update — Monday October 26, 2026 · 5 minA thin top-tier week for acromegaly (one Pituitary paper plus a handful of solid next-tier studies, including a 2026 pipeline review), while rare disease news was dominated by…
- Acromegaly Update — Monday October 5, 2026 · 7 minA thin week: no top-tier-journal acromegaly papers appeared, so Part A draws on the next tier (a radiomics model to predict somatostatin-analog response, a familial…
- Acromegaly Update — Monday September 28, 2026 · 7 minA quiet week for top-tier acromegaly literature (four papers, mostly real-world/consensus rather than trial data) paired with a livelier rare disease industry week — a first-ever…
- Acromegaly Update — Monday September 21, 2026 · 7 minThis week's acromegaly literature centers on long-term disease burden — cardiovascular morbidity, musculoskeletal disease, and precision-medicine treatment selection — while the…
- Acromegaly Update — Tuesday September 15, 2026 · 7 minIt's a quiet week for acromegaly-specific research — just one review paper worth flagging — but rare disease industry news was busy, headlined by Scholar Rock's first-ever…
- Acromegaly Update — Monday September 7, 2026 · 7 minIt's a thin week for acromegaly-specific research — no top-tier-journal hits, so we're covering the best next-tier evidence on GH-axis physiology, octreotide drug delivery, and…
- Acromegaly Update — Tuesday September 1, 2026 · 7 minIt's a quiet week for dedicated acromegaly research — no top-tier-journal hits, just a pasireotide cost-effectiveness review and a giant-adenoma case report — while the wider…
- Acromegaly Update — Monday August 31, 2026 · 7 minIt's a quiet week for acromegaly-specific research — no top-tier trials, just a handful of diagnostic and mechanistic papers — while rare disease industry news brought two new…
- Acromegaly Update — Monday August 24, 2026 · 7 minIt was a quiet week for acromegaly-specific research — three observational studies refined how we monitor and support patients rather than changing treatment — while the wider…
- Acromegaly Update — Monday August 17, 2026 · 7 minIt's an unusually rich week for acromegaly research — five new papers spanning a first-in-human antagonist trial and two large Swedish outcomes studies — while the rare disease…
- Acromegaly Update — Monday August 10, 2026 · 7 minIt's a quiet week for acromegaly-specific trial data — the research side leans mechanistic and clinical-management, headlined by a novel long-acting GH receptor antagonist —…
- Acromegaly Update — Monday August 3, 2026 · 7 minIt's a quiet week for acromegaly-specific research — no trials, just incremental papers on AI-assisted detection, surgical outcomes, and pediatric gigantism — while the broader…
- Acromegaly Update — Monday July 27, 2026 · 7 minA trio of new Pituitary papers built out the real-world case for oral paltusotine in controlled acromegaly, while on the industry side a small rare-disease repurposing startup…
- Acromegaly Update — Monday July 20, 2026 · 7 minA quiet week for acromegaly research was anchored by a strong AI-diagnosis paper in JCEM, while rare disease headlines swung between a startup's ultrasound gene-therapy bombshell…
- Acromegaly Update — Monday July 13, 2026 · 4 minIt was a quiet week for new acromegaly research, but the rare disease industry delivered its biggest story of the year — Vertex's $10 billion acquisition of Crinetics…
- Acromegaly Update — Monday July 6, 2026 · 7 minIt's a thin week for acromegaly-specific research — just one mechanistic study on tumor biology — but rare disease dealmaking was busy, headlined by Ipsen's ~$800M bet on a…
- Acromegaly Update — Monday June 29, 2026 · 7 minPaltusotine's four-year open-label data confirm durable oral control of acromegaly in patients switched from injections, while the rare disease industry absorbs a landmark…








